Tirzepatide 3ml 10mg/ml – Hilma

Tirzepatide is a new drug approved by the FDA for the treatment of type 2 diabetes mellitus. Given its potent weight-loss properties, tirzepatide is used off-label for the treatment of obesity. It acts as a dual agonist of GLP-1 and GIP to maximize benefits similar to those seen with GLP-1 drugs such as semaglutide. It is currently used as a second-line diabetes drug, like GLP-1 drugs, and administered as a subcutaneous injection once a week.